Table 1.
Gabapentin (n = 10) | Placebo (n = 16) | Overall (n = 26) | |
---|---|---|---|
Demographic Characteristics | |||
Continuous Variable | Mean (SD) | Mean (SD) | Mean (SD) |
Age (yrs)* | 45.5 (4.46) | 49.5 (4.96) | 47.9 (5.05) |
Methadone Dose (mg) | 73.0 (20.02) | 70.9 (23.16) | 71.7 (21.62) |
Peak Methadone plasma level (baseline ng/ml) | 191.5 (57.08) | 168.8 (62.32) | 177.5 (60.22) |
Trough Methadone plasma level (baseline ng/ml) | 125.8 (39.91) | 130.7 (43.16) | 128.8 (41.20) |
Categorical Variables | % | % | % |
Gender | |||
Males | 50.0 | 56.3 | 53.9 |
Race | |||
Hispanic | 60.0 | 43.8 | 50.0 |
American Indian | 10.0 | 0.0 | 3.9 |
African American | 0.0 | 25.0 | 15.4 |
Caucasian | 30.0 | 12.5 | 19.2 |
Other | 0.0 | 18.8 | 11.5 |
Marital Status | |||
Married / Living-with-partner | 50.0 | 50.0 | 50.0 |
Separated / Divorced | 30.0 | 31.3 | 30.1 |
Widowed / Never-married | 20.0 | 18.8 | 19.2 |
Education | |||
< High School | 36.0 | 40.0 | 38.0 |
High School | 32.0 | 40.0 | 36.0 |
> High School | 32.0 | 20.0 | 26.0 |
Significant group difference observed at alpha = 0.049 level of significance